163 related articles for article (PubMed ID: 34427055)
1. Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy.
Morigny P; Kaltenecker D; Zuber J; Machado J; Mehr L; Tsokanos FF; Kuzi H; Hermann CD; Voelkl M; Monogarov G; Springfeld C; Laurent V; Engelmann B; Friess H; Zörnig I; Krüger A; Krijgsveld J; Prokopchuk O; Fisker Schmidt S; Rohm M; Herzig S; Berriel Diaz M
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1333-1351. PubMed ID: 34427055
[TBL] [Abstract][Full Text] [Related]
2. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
[TBL] [Abstract][Full Text] [Related]
3. Specific miRNAs are associated with human cancer cachexia in an organ-specific manner.
Krauss T; Heisz S; Honecker J; Prokopchuk O; Martignoni M; Janssen KP; Claussnitzer M; Hauner H; Seeliger C
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1381-1394. PubMed ID: 37021483
[TBL] [Abstract][Full Text] [Related]
4. Cancer cachexia: biomarkers and the influence of age.
Geppert J; Rohm M
Mol Oncol; 2024 Feb; ():. PubMed ID: 38414161
[TBL] [Abstract][Full Text] [Related]
5. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
6. The expression landscape of cachexia-inducing factors in human cancers.
Freire PP; Fernandez GJ; de Moraes D; Cury SS; Dal Pai-Silva M; Dos Reis PP; Rogatto SR; Carvalho RF
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):947-961. PubMed ID: 32125790
[TBL] [Abstract][Full Text] [Related]
7. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
8. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Vaes RDW; van Dijk DPJ; Welbers TTJ; Blok MJ; Aberle MR; Heij L; Boj SF; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1509-1524. PubMed ID: 33047901
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma.
Zhang F; Liu W; Meng F; Jiang Q; Tang W; Liu Z; Lin X; Xue R; Zhang S; Dong L
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272562
[TBL] [Abstract][Full Text] [Related]
10. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
11. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.
Talbert EE; Lewis HL; Farren MR; Ramsey ML; Chakedis JM; Rajasekera P; Haverick E; Sarna A; Bloomston M; Pawlik TM; Zimmers TA; Lesinski GB; Hart PA; Dillhoff ME; Schmidt CR; Guttridge DC
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):358-368. PubMed ID: 29316343
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
Niu M; Song S; Su Z; Wei L; Li L; Pu W; Zhao C; Ding Y; Wang J; Cao W; Gao Q; Wang H
Br J Pharmacol; 2021 Nov; 178(22):4485-4500. PubMed ID: 34265073
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.
Yeo A; Li L; Warren L; Aponte J; Fraser D; King K; Johansson K; Barnes A; MacPhee C; Davies R; Chissoe S; Tarka E; O'Donoghue ML; White HD; Wallentin L; Waterworth D
PLoS One; 2017; 12(7):e0182115. PubMed ID: 28753643
[TBL] [Abstract][Full Text] [Related]
14. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
15. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
16. Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial.
Johnson JL; Shi Y; Snipes R; Janmohamed S; Rolfe TE; Davis B; Postle A; Macphee CH
PLoS One; 2014; 9(2):e89034. PubMed ID: 24586490
[TBL] [Abstract][Full Text] [Related]
17. Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?
Nogueira-Ferreira R; Sousa-Nunes F; Leite-Moreira A; Moreira-Costa L; Vitorino R; Lara Santos L; Moreira-Gonçalves D; Ferreira R
Inflamm Res; 2022 Aug; 71(7-8):771-783. PubMed ID: 35680678
[TBL] [Abstract][Full Text] [Related]
18. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of single-cell and bulk RNA sequencing reveals pro-fibrotic PLA2G7
Wang J; Jiang M; Xiong A; Zhang L; Luo L; Liu Y; Liu S; Ran Q; Wu D; Xiong Y; He X; Leung EL; Li G
Pharmacol Res; 2022 Aug; 182():106286. PubMed ID: 35662628
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
